Research.Patient.info
Metastatic Head-and-neck Squamous-cell Carcinoma research hub
3 indexed studies · 2 currently recruiting
- recruitingPHASE3
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
This study is looking at a new combination of medicines, ficlatuzumab and cetuximab, for people with head and neck cancer that has come back or spread, and tested negative for HPV. It aims to see if this new combination works better than cetuximab alone.
United States · Australia · Belgium - recruitingPHASE2, PHASE3
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
This study looks at a new drug, ficerafusp alfa, combined with pembrolizumab (Keytruda®) for people with advanced head and neck cancer. It compares this combination against pembrolizumab alone to see if it works better and is safe.
United States · Argentina · Australia - active not recruitingPHASE2
Phase II Trial of Pembrolizumab in Recurrent or Metastatic HNSCC
This study is testing a medicine called pembrolizumab for advanced head and neck cancer that has come back or spread. It looks at how well it works and if it's safe for people who are quite unwell.
United Kingdom